EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cardiovascular risk assessment: The key path toward precision prevention

Jianxin Li, Xiangfeng Lu iD

Chronic Diseases and Translational Medicine · 2023-12 · 9 (4) · 273-276

DOI: 10.1002/cdt3.90 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chronic Diseases and Translational Medicine, 2023-08. Verfasst von Jianxin Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical …. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
  • Key Laboratory of Cardiovascular Epidemiology Chinese Academy of Medical Sciences Beijing China.

ORCID-Profile: Xiangfeng Lu

Zitieren

APA

Li, J., & Lu, X. (2023). Cardiovascular risk assessment: The key path toward precision prevention. Chronic Diseases and Translational Medicine, 9(4), 273-276. https://doi.org/10.1002/cdt3.90

Vancouver

Li J, Lu X. Cardiovascular risk assessment: The key path toward precision prevention. Chronic Diseases and Translational Medicine. 2023;9(4):273-276. doi:10.1002/cdt3.90

BibTeX
@article{Li2023,
  author = {Li, Jianxin and Lu, Xiangfeng},
  title = {Cardiovascular risk assessment: The key path toward precision prevention},
  journal = {Chronic Diseases and Translational Medicine},
  year = {2023},
  volume = {9},
  number = {4},
  pages = {273--276},
  doi = {10.1002/cdt3.90}
}
Kostenlos starten →